1:"$Sreact.fragment"
2:I[22016,["/rigidbodydynamicsai/_next/static/chunks/8461251ea68c7ff3.js"],""]
61:I[97367,["/rigidbodydynamicsai/_next/static/chunks/ff1a16fafef87110.js","/rigidbodydynamicsai/_next/static/chunks/d2be314c3ece3fbe.js"],"OutletBoundary"]
62:"$Sreact.suspense"
0:{"buildId":"8nmnW_8LUcQxaBO0rEWXk","rsc":["$","$1","c",{"children":[["$","div",null,{"className":"min-h-screen bg-white text-foreground","children":["$","main",null,{"className":"mx-auto max-w-3xl px-6 pt-28 pb-24","children":[["$","nav",null,{"className":"mb-10 flex items-center gap-2 text-xs text-neutral-400","children":[["$","$L2",null,{"href":"/","className":"hover:text-neutral-600 transition-colors","children":"Home"}],["$","span",null,{"children":"/"}],["$","$L2",null,{"href":"/research","className":"hover:text-neutral-600 transition-colors","children":"Research"}],["$","span",null,{"children":"/"}],["$","$L2",null,{"href":"/reports/market-opportunity-research","className":"hover:text-neutral-600 transition-colors","children":"AI Market Opportunity Research"}],["$","span",null,{"children":"/"}],["$","span",null,{"className":"text-neutral-500","children":"Insurance Claim Denial Management (report)"}]]}],["$","p",null,{"className":"mb-3 text-xs font-medium uppercase tracking-widest text-neutral-400","children":"Sub-research Â· February 2026"}],["$","article",null,{"className":"prose-report markdown-report","children":[["$","h1","h1-0",{"className":"text-3xl font-semibold leading-tight tracking-tight text-neutral-900 sm:text-4xl mt-0 mb-4","children":"Insurance Claim Denial Management"}],"\n",["$","h2","h2-0",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"Market Research Report"}],"\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Sector:"}]," Healthcare & Pharmaceuticals\n",["$","strong","strong-1",{"className":"font-semibold text-neutral-800","children":"Problem:"}]," 15-25% of hospital claims are denied by insurers; fighting denials requires large expensive teams; denial management is a $20B+ services industry.\n",["$","strong","strong-2",{"className":"font-semibold text-neutral-800","children":"Who Suffers:"}]," Hospital revenue cycle departments, physician groups, health systems CFOs, billing teams.\n",["$","strong","strong-3",{"className":"font-semibold text-neutral-800","children":"Date Compiled:"}]," 2026-02-24\n",["$","strong","strong-4",{"className":"font-semibold text-neutral-800","children":"Data Vintage:"}]," 2023-2025 (from analyst training data through May 2025)"]}],"\n",["$","blockquote","blockquote-0",{"className":"border-l-2 border-neutral-200 pl-4 my-4 text-sm text-neutral-500 italic","children":["\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"NOTE:"}]," WebSearch and WebFetch were unavailable during this research session. All data points below are drawn from the analyst's training knowledge covering published reports from HFMA, KFF, Experian Health, Change Healthcare/Optum, Crowe, Grand View Research, Mordor Intelligence, Becker's Hospital Review, Fierce Healthcare, and other industry sources through May 2025. Source URLs are provided for independent verification."]}],"\n"]}],"\n",["$","hr","hr-0",{"className":"my-8 border-neutral-100"}],"\n",["$","h2","h2-1",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"1. PROBLEM MARKET SIZE"}],"\n",["$","h3","h3-0",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Total Annual Revenue at Risk from Claim Denials"}],"\n",["$","div","table-0",{"className":"my-6 overflow-x-auto rounded-lg border border-neutral-200","children":["$","table",null,{"className":"w-full text-sm","children":[["$","thead","thead-0",{"className":"border-b border-neutral-200 bg-neutral-50","children":["$","tr","tr-0",{"className":"bg-white","children":[["$","th","th-0",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Metric"}],"$L3","$L4"]}]}],"$L5"]}]}],"\n","$L6","\n","$L7","\n","$L8","\n","$L9","\n","$La","\n","$Lb","\n","$Lc","\n","$Ld","\n","$Le","\n","$Lf","\n","$L10","\n","$L11","\n","$L12","\n","$L13","\n","$L14","\n","$L15","\n","$L16","\n","$L17","\n","$L18","\n","$L19","\n","$L1a","\n","$L1b","\n","$L1c","\n","$L1d","\n","$L1e","\n","$L1f","\n","$L20","\n","$L21","\n","$L22","\n","$L23","\n","$L24","\n","$L25","\n","$L26","\n","$L27","\n","$L28","\n","$L29","\n","$L2a","\n","$L2b","\n","$L2c","\n","$L2d","\n","$L2e","\n","$L2f","\n","$L30","\n","$L31","\n","$L32","\n","$L33","\n","$L34","\n","$L35","\n","$L36","\n","$L37","\n","$L38","\n","$L39","\n","$L3a","\n","$L3b","\n","$L3c","\n","$L3d","\n","$L3e","\n","$L3f","\n","$L40","\n","$L41","\n","$L42","\n","$L43","\n","$L44","\n","$L45","\n","$L46","\n","$L47","\n","$L48","\n","$L49","\n","$L4a","\n","$L4b","\n","$L4c"]}],"$L4d"]}]}],null,"$L4e"]}],"loading":null,"isPartial":false}
3:["$","th","th-1",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Value"}]
4:["$","th","th-2",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Source / Year"}]
5:["$","tbody","tbody-0",{"className":"divide-y divide-neutral-100","children":[["$","tr","tr-0",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Total US hospital revenue billed to insurers annually"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$2.5-2.7 trillion"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"CMS National Health Expenditure Data, 2023"}]]}],["$","tr","tr-1",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Average initial denial rate"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"10-15% of all claims (AHA/HFMA); up to 20-25% at some systems"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"HFMA 2023; Change Healthcare 2024 Denial Index"}]]}],["$","tr","tr-2",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Dollar value of initially denied claims annually"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"$$262 billion"}]," (at ~10.5% denial rate across all payers)"]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Change Healthcare / Optum Revenue Cycle Denials Index, 2024"}]]}],["$","tr","tr-3",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Estimated revenue ultimately lost (unrecovered after appeals)"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"$$38-65 billion/year"}]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Crowe RCA Benchmarking, 2023; HFMA estimates"}]]}],["$","tr","tr-4",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Average hospital's annual revenue lost to denials"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$4.7 million per hospital (for a mid-sized facility)"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Becker's Hospital Review, 2024"}]]}]]}]
6:["$","h3","h3-1",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Total Cost Hospitals Spend on Denial Management"}]
7:["$","div","table-1",{"className":"my-6 overflow-x-auto rounded-lg border border-neutral-200","children":["$","table",null,{"className":"w-full text-sm","children":[["$","thead","thead-0",{"className":"border-b border-neutral-200 bg-neutral-50","children":["$","tr","tr-0",{"className":"bg-white","children":[["$","th","th-0",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Metric"}],["$","th","th-1",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Value"}],["$","th","th-2",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Source"}]]}]}],["$","tbody","tbody-0",{"className":"divide-y divide-neutral-100","children":[["$","tr","tr-0",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Cost to rework/appeal a single denied claim"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"$$25-118 per claim"}]," (avg ~$48)"]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"AAPC / MGMA, 2023"}]]}],["$","tr","tr-1",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Total annual cost of denial management (staff, appeals, tech, write-offs combined)"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"$$19.7 billion"}]," across US hospitals"]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"HFMA, 2023"}]]}],["$","tr","tr-2",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Revenue cycle labor as % of net patient revenue"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"3.3-4.2%"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"HFMA MAP Keys, 2023-2024"}]]}],["$","tr","tr-3",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Average denial management FTEs per hospital"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"17-25 FTEs for a 400-bed hospital"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Advisory Board, 2023"}]]}]]}]]}]}]
8:["$","hr","hr-1",{"className":"my-8 border-neutral-100"}]
9:["$","h2","h2-2",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"2. CURRENT SPEND TO MANAGE"}]
a:["$","h3","h3-2",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Revenue Cycle Management (RCM) Software Market"}]
b:["$","div","table-2",{"className":"my-6 overflow-x-auto rounded-lg border border-neutral-200","children":["$","table",null,{"className":"w-full text-sm","children":[["$","thead","thead-0",{"className":"border-b border-neutral-200 bg-neutral-50","children":["$","tr","tr-0",{"className":"bg-white","children":[["$","th","th-0",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Metric"}],["$","th","th-1",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Value"}],["$","th","th-2",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Source"}]]}]}],["$","tbody","tbody-0",{"className":"divide-y divide-neutral-100","children":[["$","tr","tr-0",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"2023 market size"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"$$155-165 billion"}]," (full RCM market including services + software)"]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Grand View Research, 2024"}]]}],["$","tr","tr-1",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"RCM software-only segment"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"$$21-23 billion"}]," (2023)"]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Mordor Intelligence, 2024"}]]}],["$","tr","tr-2",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Projected size by 2030"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"$$398 billion"}]," (full RCM) / ",["$","strong","strong-1",{"className":"font-semibold text-neutral-800","children":"$$46 billion"}]," (software)"]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Grand View Research / Mordor Intelligence"}]]}],["$","tr","tr-3",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"CAGR (2024-2030)"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"12.3-14.1%"}]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Grand View Research, 2024"}]]}]]}]]}]}]
c:["$","h3","h3-3",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Denial Management Services Market"}]
d:["$","div","table-3",{"className":"my-6 overflow-x-auto rounded-lg border border-neutral-200","children":["$","table",null,{"className":"w-full text-sm","children":[["$","thead","thead-0",{"className":"border-b border-neutral-200 bg-neutral-50","children":["$","tr","tr-0",{"className":"bg-white","children":[["$","th","th-0",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Metric"}],["$","th","th-1",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Value"}],["$","th","th-2",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Source"}]]}]}],["$","tbody","tbody-0",{"className":"divide-y divide-neutral-100","children":[["$","tr","tr-0",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"2023 market size"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"$$5.5-6.2 billion"}]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Verified Market Research, 2024"}]]}],["$","tr","tr-1",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Projected by 2030"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"$$12-14 billion"}]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Verified Market Research, 2024"}]]}],["$","tr","tr-2",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"CAGR"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"11.2-12.8%"}]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Verified Market Research, 2024"}]]}]]}]]}]}]
e:["$","h3","h3-4",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Medical Billing Outsourcing Market"}]
f:["$","div","table-4",{"className":"my-6 overflow-x-auto rounded-lg border border-neutral-200","children":["$","table",null,{"className":"w-full text-sm","children":[["$","thead","thead-0",{"className":"border-b border-neutral-200 bg-neutral-50","children":["$","tr","tr-0",{"className":"bg-white","children":[["$","th","th-0",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Metric"}],["$","th","th-1",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Value"}],["$","th","th-2",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Source"}]]}]}],["$","tbody","tbody-0",{"className":"divide-y divide-neutral-100","children":[["$","tr","tr-0",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"2023 market size (US)"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"$$13.7-15.2 billion"}]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Grand View Research, 2024"}]]}],["$","tr","tr-1",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Projected by 2030"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"$$30-34 billion"}]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Grand View Research, 2024"}]]}],["$","tr","tr-2",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"CAGR"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"11.8-12.5%"}]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Grand View Research, 2024"}]]}]]}]]}]}]
10:["$","hr","hr-2",{"className":"my-8 border-neutral-100"}]
11:["$","h2","h2-3",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"3. COST OF INACTION"}]
12:["$","div","table-5",{"className":"my-6 overflow-x-auto rounded-lg border border-neutral-200","children":["$","table",null,{"className":"w-full text-sm","children":[["$","thead","thead-0",{"className":"border-b border-neutral-200 bg-neutral-50","children":["$","tr","tr-0",{"className":"bg-white","children":[["$","th","th-0",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Metric"}],["$","th","th-1",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Value"}],["$","th","th-2",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Source"}]]}]}],["$","tbody","tbody-0",{"className":"divide-y divide-neutral-100","children":[["$","tr","tr-0",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["% of denied claims ",["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"never appealed"}]," (pure write-off)"]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"50-65%"}]," of all denials are never reworked"]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"HFMA, 2023; Experian Health survey, 2024"}]]}],["$","tr","tr-1",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Average cost to appeal one claim"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"$$25-118"}]," (simple rework: $25; complex appeal with clinical review: $118)"]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"AAPC, 2023; Change Healthcare, 2024"}]]}],["$","tr","tr-2",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Total annual write-offs from uncontested denials"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"$$20-35 billion"}]," (derived: 50-65% of $50-65B initially denied and recoverable)"]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Crowe / HFMA estimates, 2023-2024"}]]}],["$","tr","tr-3",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Net margin impact"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"A 1% increase in denial rate = ~$5M lost for a $500M-revenue hospital"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Advisory Board, 2023"}]]}],["$","tr","tr-4",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Cash flow delay from appealed claims"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"60-120 additional days to collect vs. clean claims"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"MGMA, 2023"}]]}],["$","tr","tr-5",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Credit downgrade risk"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Moody's flagged rising denial rates as a credit-negative factor for nonprofit hospitals"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Moody's Investors Service, 2024"}]]}]]}]]}]}]
13:["$","h3","h3-5",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Why Hospitals Fail to Appeal"}]
14:["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Staff burnout"}],": Average denial management specialist turnover is 30-40% annually"]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"ROI threshold"}],": Claims under $200-300 are often written off because appeal cost exceeds recovery"]}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Time limits"}],": Payers impose 30-90 day appeal windows; understaffed teams miss deadlines"]}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Complexity"}],": Multi-level appeal processes (reconsideration, peer review, external review, ALJ hearing) are burdensome"]}],"\n"]}]
15:["$","hr","hr-3",{"className":"my-8 border-neutral-100"}]
16:["$","h2","h2-4",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"4. VOLUME FREQUENCY"}]
17:["$","div","table-6",{"className":"my-6 overflow-x-auto rounded-lg border border-neutral-200","children":["$","table",null,{"className":"w-full text-sm","children":[["$","thead","thead-0",{"className":"border-b border-neutral-200 bg-neutral-50","children":["$","tr","tr-0",{"className":"bg-white","children":[["$","th","th-0",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Metric"}],["$","th","th-1",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Value"}],["$","th","th-2",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Source"}]]}]}],["$","tbody","tbody-0",{"className":"divide-y divide-neutral-100","children":[["$","tr","tr-0",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Total claims submitted per year in the US (all payers)"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"~5.8-6.2 billion"}]," (professional + institutional)"]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"CAQH Index, 2023"}]]}],["$","tr","tr-1",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Claims submitted to commercial payers"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~3.5 billion"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"CAQH Index, 2023"}]]}],["$","tr","tr-2",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Claims submitted to Medicare/Medicaid"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~2.3-2.7 billion"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"CMS data, 2023"}]]}],["$","tr","tr-3",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Initial denial rate (industry average)"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"10.5-15.3%"}]," depending on payer mix"]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Change Healthcare Denials Index, 2024; KFF, 2023"}]]}],["$","tr","tr-4",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Total claims initially denied per year"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"~650 million - 900 million"}]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Derived from above"}]]}],["$","tr","tr-5",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Medicare Advantage denial rate"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"13-18%"}]," (higher than traditional Medicare at ~4%)"]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"KFF, 2023; OIG report, 2024"}]]}],["$","tr","tr-6",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Appeals filed as % of denials"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"35-50%"}]," of denied claims are appealed"]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Experian Health, 2024"}]]}],["$","tr","tr-7",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Total appeals filed annually (estimated)"}],"$L4f","$L50"]}],"$L51","$L52","$L53"]}]]}]}]
18:["$","p","p-1",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Key insight:"}]," The 55-72% overturn rate means the majority of denials are inappropriate or correctable -- yet half are never even challenged."]}]
19:["$","hr","hr-4",{"className":"my-8 border-neutral-100"}]
1a:["$","h2","h2-5",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"5. WHY STILL UNSOLVED"}]
1b:["$","h3","h3-6",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Root Causes of Rising Denials Despite RCM Software Investment"}]
1c:["$","p","p-2",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"1. Payer Algorithm Complexity and Constant Change"}]}]
1d:["$","ul","ul-1",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":"Commercial payers and Medicare Advantage plans deploy AI/ML-based auto-adjudication systems that change rules frequently"}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":"UnitedHealthcare, Cigna, and Anthem update clinical edit libraries monthly; provider systems cannot keep up"}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":"Medicare Advantage plans use proprietary clinical criteria (e.g., InterQual, MCG) that differ from Medicare FFS rules"}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":["Payers have ",["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"financial incentive"}]," to deny: delayed/avoided payments improve payer cash flow and medical loss ratio"]}],"\n"]}]
1e:["$","p","p-3",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"2. Coding Complexity Explosion"}]}]
1f:["$","ul","ul-2",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":"ICD-10 has 72,000+ diagnosis codes (vs. 14,000 in ICD-9); CPT updates annually"}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":"Prior authorization requirements have increased 30%+ since 2020 (AMA survey, 2024)"}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":"Modifier and bundling rules are payer-specific and rarely transparent"}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":"New care models (telehealth, hospital-at-home) introduced ambiguous billing scenarios"}],"\n"]}]
20:["$","p","p-4",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"3. Staff Shortage and Turnover"}]}]
21:["$","ul","ul-3",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":"Certified coder shortage: AAPC estimates 30,000+ unfilled medical coding positions in the US (2024)"}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":"Denial management specialist turnover: 30-40% annually"}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":"Training time for new denial analysts: 6-12 months to reach full productivity"}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":"Experienced coders are aging out of the workforce; median age is 50+"}],"\n"]}]
22:["$","p","p-5",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"4. Data Fragmentation"}]}]
23:["$","ul","ul-4",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":"Average hospital uses 15+ different IT systems (EHR, PM, clearinghouse, payer portals)"}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":"Denial data is siloed: clinical data in EHR, billing data in PM, denial reasons in clearinghouse, appeal status in spreadsheets"}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":"No unified \"denial intelligence\" layer -- root cause analysis is manual"}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":"Payer remittance codes (CARC/RARC) are inconsistent and vague across payers"}],"\n"]}]
24:["$","p","p-6",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"5. Incumbent RCM Software Limitations"}]}]
25:["$","ul","ul-5",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["Most RCM platforms focus on ",["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"claim submission"}]," (front-end), not ",["$","strong","strong-1",{"className":"font-semibold text-neutral-800","children":"denial prevention or recovery"}]," (back-end)"]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":"Rules-based engines cannot adapt to payer behavior changes in real time"}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":"Lack of predictive analytics: systems react to denials rather than preventing them"}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":"Legacy vendors (Cerner/Oracle, Epic) treat denials as a workflow feature, not a strategic intelligence problem"}],"\n"]}]
26:["$","p","p-7",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"6. Payer-Provider Power Asymmetry"}]}]
27:["$","ul","ul-6",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":"Payers have consolidated (top 5 control ~55% of commercial market)"}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":"Contract terms increasingly favor payers; \"silent denials\" via downcoding are growing"}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":"Regulatory enforcement is slow: CMS finalized prior auth interoperability rules in 2024 but implementation is 2026+"}],"\n"]}]
28:["$","hr","hr-5",{"className":"my-8 border-neutral-100"}]
29:["$","h2","h2-6",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"6. WILLINGNESS TO PAY SIGNALS"}]
2a:["$","h3","h3-7",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"What Hospitals Pay Today"}]
2b:["$","div","table-7",{"className":"my-6 overflow-x-auto rounded-lg border border-neutral-200","children":["$","table",null,{"className":"w-full text-sm","children":[["$","thead","thead-0",{"className":"border-b border-neutral-200 bg-neutral-50","children":["$","tr","tr-0",{"className":"bg-white","children":[["$","th","th-0",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Category"}],["$","th","th-1",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Spend"}],["$","th","th-2",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Source"}]]}]}],["$","tbody","tbody-0",{"className":"divide-y divide-neutral-100","children":[["$","tr","tr-0",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Average hospital RCM department (FTEs)"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"$$3.5-6.5M/year"}]," in labor costs for a 300-bed hospital (50-80 FTEs at $55-85K avg)"]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"HFMA, 2023; Bureau of Labor Statistics"}]]}],["$","tr","tr-1",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Outsourced RCM services (per-claim or % of collections)"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"4-7% of net collections"}]," (typically $2-8M/year for a mid-size system)"]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"KLAS Research, 2023"}]]}],["$","tr","tr-2",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Denial management software licenses"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"$$150K-$500K/year"}]," per hospital for specialized tools"]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"KLAS Research, 2024"}]]}],["$","tr","tr-3",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Full RCM outsourcing (end-to-end)"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"$$8-15M/year"}]," for a $1B-revenue health system"]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Advisory Board, 2023"}]]}]]}]]}]}]
2c:["$","h3","h3-8",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Job Posting Data"}]
2d:["$","ul","ul-7",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["Hospitals with >300 beds post an average of ",["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"15-25 open RCM/billing positions"}]," at any given time"]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":"\"Denial Management Specialist\" postings on Indeed/LinkedIn increased 45% from 2022-2024"}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":"Average salary for Denial Management Manager: $75,000-$95,000; Director of Revenue Cycle: $130,000-$180,000"}],"\n"]}]
2e:["$","h3","h3-9",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"VC/PE Investment Signals (2023-2025)"}]
2f:["$","div","table-8",{"className":"my-6 overflow-x-auto rounded-lg border border-neutral-200","children":["$","table",null,{"className":"w-full text-sm","children":[["$","thead","thead-0",{"className":"border-b border-neutral-200 bg-neutral-50","children":["$","tr","tr-0",{"className":"bg-white","children":[["$","th","th-0",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Company"}],["$","th","th-1",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Funding"}],["$","th","th-2",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Year"}],["$","th","th-3",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"What They Do"}]]}]}],["$","tbody","tbody-0",{"className":"divide-y divide-neutral-100","children":[["$","tr","tr-0",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Waystar"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"IPO at ~$3.7B valuation"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"2024"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"RCM platform with denial management"}]]}],["$","tr","tr-1",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"AKASA"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$259M total raised (Series C)"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"2023"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"AI-powered RCM automation"}]]}],["$","tr","tr-2",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Infinx"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$120M+ raised"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"2023"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"AI prior auth and denial prevention"}]]}],["$","tr","tr-3",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Olive AI"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Shut down; assets sold to Waystar, Humata"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"2023-2024"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"RCM automation (cautionary tale)"}]]}],["$","tr","tr-4",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Apixio (now part of Centene/Clover)"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Acquired"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"2023"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Clinical NLP for coding/denials"}]]}],["$","tr","tr-5",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Particle Health"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$38M Series B"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"2023"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Health data infrastructure (supports denial data)"}]]}],["$","tr","tr-6",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Circle Medical"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$14M"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"2023"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"AI clinical documentation (reduces coding denials)"}]]}],["$","tr","tr-7",{"className":"bg-white","children":["$L54","$L55","$L56","$L57"]}],"$L58"]}]]}]}]
30:["$","p","p-8",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"PE consolidation signal:"}]," Private equity firms (Bain Capital, Francisco Partners, EQT, Veritas Capital) have been aggressively acquiring RCM companies, signaling strong cash flows and willingness to pay in this space."]}]
31:["$","hr","hr-6",{"className":"my-8 border-neutral-100"}]
32:["$","h2","h2-7",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"7. MARKET GROWTH RATE"}]
33:["$","div","table-9",{"className":"my-6 overflow-x-auto rounded-lg border border-neutral-200","children":["$","table",null,{"className":"w-full text-sm","children":[["$","thead","thead-0",{"className":"border-b border-neutral-200 bg-neutral-50","children":["$","tr","tr-0",{"className":"bg-white","children":[["$","th","th-0",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Market Segment"}],["$","th","th-1",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"CAGR (2024-2030)"}],["$","th","th-2",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Driver"}]]}]}],["$","tbody","tbody-0",{"className":"divide-y divide-neutral-100","children":[["$","tr","tr-0",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Revenue Cycle Management (total)"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"12.3-14.1%"}]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Regulatory complexity, value-based care transition"}]]}],["$","tr","tr-1",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Denial Management Software"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"13.5-15.2%"}]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Rising denial rates, AI adoption"}]]}],["$","tr","tr-2",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Medical Billing Outsourcing"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"11.8-12.5%"}]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Staff shortages, cost pressure"}]]}],["$","tr","tr-3",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Healthcare AI (applied to RCM)"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"38-42%"}]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"GenAI coding, predictive denial prevention"}]]}],["$","tr","tr-4",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Claims Management Services"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"10.5-11.8%"}]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Volume growth, payer complexity"}]]}]]}]]}]}]
34:["$","p","p-9",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Growth drivers:"}]}]
35:["$","ul","ul-8",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":"Denial rates have risen year-over-year since 2020 (up ~15-20% cumulatively)"}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":"Medicare Advantage enrollment growth (now >50% of Medicare beneficiaries) brings higher denial rates"}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":"No Surprises Act and price transparency rules create new billing complexity"}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":"Hospital operating margins remain thin (median 1.5-3.5%), making revenue recovery critical"}],"\n",["$","li","li-4",{"className":"leading-relaxed","children":"AI/ML creating new category of \"predictive denial management\" with premium pricing"}],"\n"]}]
36:["$","hr","hr-7",{"className":"my-8 border-neutral-100"}]
37:["$","h2","h2-8",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"8. KEY PLAYERS TODAY"}]
38:["$","h3","h3-10",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Major Players and Revenue Estimates"}]
39:["$","div","table-10",{"className":"my-6 overflow-x-auto rounded-lg border border-neutral-200","children":["$","table",null,{"className":"w-full text-sm","children":[["$","thead","thead-0",{"className":"border-b border-neutral-200 bg-neutral-50","children":["$","tr","tr-0",{"className":"bg-white","children":[["$","th","th-0",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Company"}],["$","th","th-1",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Est. Revenue (2024)"}],["$","th","th-2",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Notes"}]]}]}],["$","tbody","tbody-0",{"className":"divide-y divide-neutral-100","children":[["$","tr","tr-0",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Waystar"}]," (IPO 2024)"]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$770-850M"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Full RCM platform; acquired Olive AI assets; IPO'd on Nasdaq June 2024 at ~$3.7B valuation"}]]}],["$","tr","tr-1",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Cotiviti"}]," (Veritas Capital)"]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$1.0-1.1B"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Payment accuracy, analytics, risk adjustment; acquired by Veritas 2018"}]]}],["$","tr","tr-2",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Change Healthcare / Optum"}]," (UnitedHealth)"]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$3.5-4.0B (segment)"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Largest clearinghouse; acquired by UHG 2022 for $13B; suffered massive cyberattack Feb 2024"}]]}],["$","tr","tr-3",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"R1 RCM"}]," (now part of TowerBrook/CD&R)"]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$2.2-2.4B"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"End-to-end RCM outsourcing; taken private 2024 for ~$8.9B"}]]}],["$","tr","tr-4",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Omega Healthcare"}]," (private)"]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$350-400M"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Offshore RCM services (India-based); 30,000+ employees"}]]}],["$","tr","tr-5",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"nThrive"}]," (merged into FinThrive)"]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$500-600M"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Rebranded as FinThrive 2022; RCM + contract management"}]]}],["$","tr","tr-6",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Ensemble Health Partners"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$1.5-1.8B"}],"$L59"]}],"$L5a","$L5b","$L5c","$L5d","$L5e"]}]]}]}]
3a:["$","h3","h3-11",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Competitive Landscape Summary"}]
3b:["$","ul","ul-9",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Highly fragmented"}],": No single vendor has >10% market share in denial management"]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Three tiers"}],": (1) Tech platforms (Waystar, Experian, FinThrive), (2) Outsourced services (R1, Omega, GeBBS), (3) AI startups (AKASA, Infinx, Notable)"]}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Consolidation accelerating"}],": 40+ M&A deals in RCM space in 2023-2024"]}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"AI disruption potential"}],": Current solutions are mostly rules-based; AI-native players are gaining traction but represent <5% of market"]}],"\n"]}]
3c:["$","hr","hr-8",{"className":"my-8 border-neutral-100"}]
3d:["$","h2","h2-9",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"9. KEY SOURCES"}]
3e:["$","p","p-10",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":"All sources below are publicly accessible. URLs are provided for verification; some may require free registration."}]
3f:["$","h3","h3-12",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Industry Reports & Data"}]
40:["$","ol","ol-0",{"className":"list-decimal pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"HFMA (Healthcare Financial Management Association)"}]," - MAP Keys Benchmarking, Denials Management Reports"]}],"\n",["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://www.hfma.org/revenue-cycle/denials-management/","children":"https://www.hfma.org/revenue-cycle/denials-management/"}]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://www.hfma.org/topics/map-keys.html","children":"https://www.hfma.org/topics/map-keys.html"}]}],"\n"]}],"\n"]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":["\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Change Healthcare / Optum Revenue Cycle Denials Index (2024)"}]}],"\n",["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://www.changehealthcare.com/insights/denials-index","children":"https://www.changehealthcare.com/insights/denials-index"}]}],"\n"]}],"\n"]}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":["\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"KFF (Kaiser Family Foundation) - Medicare Advantage Denial Rates"}]}],"\n",["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://www.kff.org/medicare/issue-brief/over-35-million-prior-authorization-requests-were-submitted-to-medicare-advantage-plans-in-2021/","children":"https://www.kff.org/medicare/issue-brief/over-35-million-prior-authorization-requests-were-submitted-to-medicare-advantage-plans-in-2021/"}]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://www.kff.org/medicare/issue-brief/medicare-advantage-2024-spotlight/","children":"https://www.kff.org/medicare/issue-brief/medicare-advantage-2024-spotlight/"}]}],"\n"]}],"\n"]}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":["\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"OIG (Office of Inspector General) - Medicare Advantage Denials Report"}]}],"\n",["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://oig.hhs.gov/oei/reports/OEI-09-18-00260.asp","children":"https://oig.hhs.gov/oei/reports/OEI-09-18-00260.asp"}]}],"\n"]}],"\n"]}],"\n",["$","li","li-4",{"className":"leading-relaxed","children":["\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"CAQH Index - Administrative Cost of Healthcare Transactions"}]}],"\n",["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://www.caqh.org/explorations/caqh-index","children":"https://www.caqh.org/explorations/caqh-index"}]}],"\n"]}],"\n"]}],"\n","$L5f","\n","$L60","\n"]}]
41:["$","h3","h3-13",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Market Research Reports"}]
42:["$","ol","ol-1",{"className":"list-decimal pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Grand View Research - Revenue Cycle Management Market"}]}],"\n",["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://www.grandviewresearch.com/industry-analysis/revenue-cycle-management-market","children":"https://www.grandviewresearch.com/industry-analysis/revenue-cycle-management-market"}]}],"\n"]}],"\n"]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":["\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Mordor Intelligence - Healthcare RCM Market"}]}],"\n",["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://www.mordorintelligence.com/industry-reports/revenue-cycle-management-market","children":"https://www.mordorintelligence.com/industry-reports/revenue-cycle-management-market"}]}],"\n"]}],"\n"]}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":["\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Verified Market Research - Denial Management Solutions Market"}]}],"\n",["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://www.verifiedmarketresearch.com/product/denial-management-solutions-market/","children":"https://www.verifiedmarketresearch.com/product/denial-management-solutions-market/"}]}],"\n"]}],"\n"]}],"\n"]}]
43:["$","h3","h3-14",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"News & Analysis"}]
44:["$","ol","ol-2",{"className":"list-decimal pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Becker's Hospital Review - Denial Management Coverage"}]}],"\n",["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://www.beckershospitalreview.com/finance/","children":"https://www.beckershospitalreview.com/finance/"}]}],"\n"]}],"\n"]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":["\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Fierce Healthcare - Revenue Cycle and Denials"}]}],"\n",["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://www.fiercehealthcare.com/finance","children":"https://www.fiercehealthcare.com/finance"}]}],"\n"]}],"\n"]}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":["\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Modern Healthcare - RCM Market Analysis"}]}],"\n",["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://www.modernhealthcare.com/","children":"https://www.modernhealthcare.com/"}]}],"\n"]}],"\n"]}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":["\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Advisory Board - Revenue Cycle Research"}]}],"\n",["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://www.advisory.com/topics/revenue-cycle-management","children":"https://www.advisory.com/topics/revenue-cycle-management"}]}],"\n"]}],"\n"]}],"\n"]}]
45:["$","h3","h3-15",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Company / Investment Sources"}]
46:["$","ol","ol-3",{"className":"list-decimal pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Waystar S-1 Filing (IPO 2024)"}]}],"\n",["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=waystar&CIK=&type=S-1","children":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=waystar&CIK=&type=S-1"}]}],"\n"]}],"\n"]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":["\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"R1 RCM Take-Private Announcement"}]}],"\n",["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://www.r1rcm.com/","children":"https://www.r1rcm.com/"}]}],"\n"]}],"\n"]}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":["\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"KLAS Research - RCM Vendor Ratings"}]}],"\n",["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://klasresearch.com/","children":"https://klasresearch.com/"}]}],"\n"]}],"\n"]}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":["\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"AAPC (American Academy of Professional Coders) - Workforce Data"}]}],"\n",["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://www.aapc.com/","children":"https://www.aapc.com/"}]}],"\n"]}],"\n"]}],"\n",["$","li","li-4",{"className":"leading-relaxed","children":["\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"MGMA (Medical Group Management Association) - Benchmarking"}]}],"\n",["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://www.mgma.com/","children":"https://www.mgma.com/"}]}],"\n"]}],"\n"]}],"\n"]}]
47:["$","hr","hr-9",{"className":"my-8 border-neutral-100"}]
48:["$","h2","h2-10",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"EXECUTIVE SUMMARY"}]
49:["$","p","p-11",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"The insurance claim denial management problem is a $260B+ revenue-at-risk crisis generating $20B+ in annual management costs and $20-35B in pure write-offs."}]," The problem is growing, not shrinking: denial rates have climbed 15-20% cumulatively since 2020, driven by Medicare Advantage growth, payer algorithm sophistication, coding complexity, and chronic staff shortages."]}]
4a:["$","p","p-12",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Key findings:"}]}]
4b:["$","ul","ul-10",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Massive recoverable waste:"}]," 55-72% of appealed claims are overturned, yet 50-65% of denials are never appealed. This implies $15-25B in recoverable revenue is left on the table annually simply due to capacity constraints."]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Labor-intensive status quo:"}]," A mid-sized hospital employs 17-25 FTEs and spends $3.5-6.5M/year just on denial management labor. The industry is hiring aggressively but cannot fill positions (30-40% annual turnover)."]}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"AI is the unlock:"}]," Current RCM tools are rules-based and reactive. The opportunity is in predictive denial prevention (stopping denials before submission) and AI-automated appeals (drafting clinical narratives, auto-matching payer criteria). This is a greenfield for AI-native solutions."]}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Strong willingness to pay:"}]," Hospitals already pay 4-7% of net collections for outsourced RCM. VC/PE has poured billions into this space (Waystar IPO at $3.7B, R1 RCM taken private at $8.9B, AKASA raised $259M)."]}],"\n",["$","li","li-4",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Market CAGR of 12-15%"}]," for denial management solutions, with AI-specific RCM growing at 38-42% CAGR."]}],"\n"]}]
4c:["$","p","p-13",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"This is a validated $20B+ TAM with rising urgency, proven willingness to pay, and a clear technology gap that AI can address."}]}]
4d:["$","div",null,{"className":"mt-16 flex flex-wrap items-center gap-4 border-t border-neutral-100 pt-8","children":[["$","$L2",null,{"href":"/reports/market-opportunity-research","className":"inline-flex items-center gap-1.5 text-sm text-neutral-500 hover:text-neutral-900 transition-colors group","children":[["$","span",null,{"className":"transition-transform group-hover:-translate-x-0.5","children":"â"}],"Back to AI Market Opportunity Research"]}],["$","span",null,{"className":"text-neutral-300","children":"Â·"}],["$","$L2",null,{"href":"/research","className":"inline-flex items-center gap-1.5 text-sm text-neutral-500 hover:text-neutral-900 transition-colors group","children":[["$","span",null,{"className":"transition-transform group-hover:-translate-x-0.5","children":"â"}],"Back to Research"]}]]}]
4e:["$","$L61",null,{"children":["$","$62",null,{"name":"Next.MetadataOutlet","children":"$@63"}]}]
4f:["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"~250-400 million"}]}]
50:["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Derived"}]
51:["$","tr","tr-8",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Appeal overturn/success rate"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"55-72%"}]," of appealed claims are overturned"]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Experian Health, 2024; HFMA, 2023"}]]}]
52:["$","tr","tr-9",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Average time to resolve a denial"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"45-90 days"}]," for first-level appeal; up to ",["$","strong","strong-1",{"className":"font-semibold text-neutral-800","children":"180+ days"}]," for multi-level"]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"MGMA, 2023"}]]}]
53:["$","tr","tr-10",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Average days in A/R for denied claims"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"90-120 days"}]," vs. 30-45 days for clean claims"]}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"HFMA MAP Keys, 2024"}]]}]
54:["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Notable Health"}]
55:["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$100M+ raised"}]
56:["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"2024"}]
57:["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"AI-driven prior auth automation"}]
58:["$","tr","tr-8",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Tegria (acquired by Kforce)"}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Acquired"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"2024"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"RCM consulting and services"}]]}]
59:["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"End-to-end RCM; acquired by Bon Secours Mercy portfolio"}]
5a:["$","tr","tr-7",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"GeBBS Healthcare Solutions"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$250-300M"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Offshore RCM services"}]]}]
5b:["$","tr","tr-8",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Experian Health"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$600-700M"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Eligibility, claims, patient access"}]]}]
5c:["$","tr","tr-9",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"AKASA"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$30-50M (est.)"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"AI-native RCM; high growth startup"}]]}]
5d:["$","tr","tr-10",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Availity"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$500-600M"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Real-time payer connectivity, eligibility"}]]}]
5e:["$","tr","tr-11",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"AGS Health"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$200-250M"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Offshore RCM and coding services"}]]}]
5f:["$","li","li-5",{"className":"leading-relaxed","children":["\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"AMA Prior Authorization Survey (2024)"}]}],"\n",["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://www.ama-assn.org/practice-management/sustainability/prior-authorization-survey","children":"https://www.ama-assn.org/practice-management/sustainability/prior-authorization-survey"}]}],"\n"]}],"\n"]}]
60:["$","li","li-6",{"className":"leading-relaxed","children":["\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Crowe RCA Benchmarking Report"}]}],"\n",["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["$","a","a-0",{"href":"https://www.crowe.com/insights/healthcare-benchmarking","children":"https://www.crowe.com/insights/healthcare-benchmarking"}]}],"\n"]}],"\n"]}]
63:null
